Handling Missing Modalities in Multimodal Survival Prediction for Non-Small Cell Lung Cancer

📅 2026-01-15
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
This study addresses the challenge of multimodal survival prediction in non-small cell lung cancer, where missing data across CT imaging, whole-slide pathology images (WSI), and clinical records often hinder the clinical deployment of deep learning models. To overcome this limitation, the authors propose a missingness-aware multimodal survival prediction framework that leverages foundation models to extract modality-specific features and introduces a missingness-aware encoding mechanism. This design enables the model to adaptively utilize available information without discarding incomplete samples or resorting to imputation, while dynamically adjusting each modality’s contribution during intermediate fusion. Experimental results demonstrate that the proposed approach significantly outperforms both unimodal baselines and early/late fusion strategies under naturally occurring missing modalities, achieving a C-index of 73.30 when fusing WSI and clinical data, thereby confirming its effectiveness and robustness.

Technology Category

Application Category

📝 Abstract
Accurate survival prediction in Non-Small Cell Lung Cancer (NSCLC) requires the integration of heterogeneous clinical, radiological, and histopathological information. While Multimodal Deep Learning (MDL) offers a promises for precision prognosis and survival prediction, its clinical applicability is severely limited by small cohort sizes and the presence of missing modalities, often forcing complete-case filtering or aggressive imputation. In this work, we present a missing-aware multimodal survival framework that integrates Computed Tomography (CT), Whole-Slide Histopathology (WSI) Images, and structured clinical variables for overall survival modeling in unresectable stage II-III NSCLC. By leveraging Foundation Models (FM) for modality-specific feature extraction and a missing-aware encoding strategy, the proposed approach enables intermediate multimodal fusion under naturally incomplete modality profiles. The proposed architecture is resilient to missing modalities by design, allowing the model to utilize all available data without being forced to drop patients during training or inference. Experimental results demonstrate that intermediate fusion consistently outperforms unimodal baselines as well as early and late fusion strategies, with the strongest performance achieved by the fusion of WSI and clinical modalities (73.30 C-index). Further analyses of modality importance reveal an adaptive behavior in which less informative modalities, i.e., CT modality, are automatically down-weighted and contribute less to the final survival prediction.
Problem

Research questions and friction points this paper is trying to address.

missing modalities
multimodal survival prediction
Non-Small Cell Lung Cancer
incomplete data
clinical applicability
Innovation

Methods, ideas, or system contributions that make the work stand out.

missing-aware multimodal fusion
foundation models
intermediate fusion
survival prediction
non-small cell lung cancer
🔎 Similar Papers
No similar papers found.
Filippo Ruffini
Filippo Ruffini
Università Campus Bio-medico di Roma
Artificial IntelligenceMedical image AnalysisComputer VisionDeep Learning
C
C. M. Caruso
Unit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
C
C. Tacconi
Research Unit of Anatomical Pathology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
L
L. Nibid
Anatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
F
Francesca Miccolis
Department of Engineering ‘Enzo Ferrari’, University of Modena and Reggio Emilia, Modena, Italy.
Marta Lovino
Marta Lovino
Assistant Professor, University of Modena and Reggio Emilia
Bioinformatics
C
Carlo Greco
Research Unit of Radiation Oncology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
E
E. Ippolito
Research Unit of Radiation Oncology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
M
Michele Fiore
Research Unit of Radiation Oncology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
A
A. Cortellini
Department of Medicine and Surgery, Università Campus Bio-Medico di Roma,Roma, Italy.
B
B. B. Zobel
Operative Research Unit of Radiology and Interventional Radiology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.
G
Giuseppe Perrone
Anatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
B
Bruno Vincenzi
Department of Medicine and Surgery, Università Campus Bio-Medico di Roma,Roma, Italy.
C
Claudio Marrocco
University of Cassino and Southern Lazio, Cassino, Italy.
A
Alessandro Bria
University of Cassino and Southern Lazio, Cassino, Italy.
E
Elisa Ficarra
Department of Engineering ‘Enzo Ferrari’, University of Modena and Reggio Emilia, Modena, Italy.
Sara Ramella
Sara Ramella
Associate Professor of Radiation Oncology Campus Bio-Medico University of Rome
Radioterapia Oncologica
V
V. Guarrasi
Unit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
P
P. Soda
Unit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.